Sun Pharmaceuticals earned the highest revenue from its cardic drug formulation, Rosuvas, with a value of over 3.8 billion Indian rupees in February 2022. This was closely followed by their pain and analgesics formulation, Volini that same year.
Revenue of Sun Pharmaceutical Industries Limited across India in February 2022, by leading therapy drug
(in billion Indian rupees)
Characteristic
Revenue in billion Indian rupees
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Motilal Oswal Group. (March 8, 2022). Revenue of Sun Pharmaceutical Industries Limited across India in February 2022, by leading therapy drug (in billion Indian rupees) [Graph]. In Statista. Retrieved August 25, 2024, from https://www.statista.com/statistics/1096917/india-sun-pharma-revenue-by-therapy-drugs/
Motilal Oswal Group. "Revenue of Sun Pharmaceutical Industries Limited across India in February 2022, by leading therapy drug (in billion Indian rupees)." Chart. March 8, 2022. Statista. Accessed August 25, 2024. https://www.statista.com/statistics/1096917/india-sun-pharma-revenue-by-therapy-drugs/
Motilal Oswal Group. (2022). Revenue of Sun Pharmaceutical Industries Limited across India in February 2022, by leading therapy drug (in billion Indian rupees). Statista. Statista Inc.. Accessed: August 25, 2024. https://www.statista.com/statistics/1096917/india-sun-pharma-revenue-by-therapy-drugs/
Motilal Oswal Group. "Revenue of Sun Pharmaceutical Industries Limited across India in February 2022, by Leading Therapy Drug (in Billion Indian Rupees)." Statista, Statista Inc., 8 Mar 2022, https://www.statista.com/statistics/1096917/india-sun-pharma-revenue-by-therapy-drugs/
Motilal Oswal Group, Revenue of Sun Pharmaceutical Industries Limited across India in February 2022, by leading therapy drug (in billion Indian rupees) Statista, https://www.statista.com/statistics/1096917/india-sun-pharma-revenue-by-therapy-drugs/ (last visited August 25, 2024)
Revenue of Sun Pharmaceutical Industries Limited across India in February 2022, by leading therapy drug (in billion Indian rupees) [Graph], Motilal Oswal Group, March 8, 2022. [Online]. Available: https://www.statista.com/statistics/1096917/india-sun-pharma-revenue-by-therapy-drugs/